Rafael holdings reports fourth quarter and full year fiscal 2021 financial and operating results and provides business update

We expect rafael pharmaceuticals to report top line data from its avenger 500 phase 3 registrational clinical trial in metastatic pancreatic cancer this calendar year
RFL Ratings Summary
RFL Quant Ranking